1. Predictors of Nonseroconversion after SARS-CoV-2 Infection
- Author
-
Liu, Weimin, Russell, Ronnie M., Bibollet-Ruche, Frederic, Skelly, Ashwin N., Sherrill-Mix, Scott, Freeman, Drew A., Stoltz, Regina, Lindemuth, Emily, Lee, Fang-Hua, Sterrett, Sarah, Bar, Katharine J., Erdmann, Nathaniel, Gouma, Sigrid, Hensley, Scott E., Ketas, Thomas, Cupo, Albert, Portillo, Victor M. Cruz, Moore, John P., Bieniasz, Paul D., Hatziioannou, Theodora, Massey, Greer, Minyard, Mary-Beth, Saag, Michael S., Davis, Randall S., Shaw, George M., Britt, William J., Leal, Sixto M., Jr., Goepfert, Paul, and Hahn, Beatrice H.
- Subjects
Development and progression ,Research ,Patient outcomes ,Antigen-antibody reactions -- Research ,Immunologic research ,COVID-19 -- Development and progression -- Patient outcomes ,Immunological research - Abstract
Coronavirus disease (COVID-19) is typically diagnosed by reverse transcription PCR (RT-PCR) amplification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA from nasopharyngeal fluids (1). RT-PCR yields cycle threshold ([C.sub.t]) [...]
- Published
- 2021
- Full Text
- View/download PDF